{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:02:54Z","timestamp":1784822574701,"version":"3.55.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS092823"],"award-info":[{"award-number":["R01NS092823"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.nbd.2018.03.008","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T23:42:10Z","timestamp":1521416530000},"page":"72-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7944-9676","authenticated-orcid":false,"given":"Caleb","family":"Pitcairn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willayat Yousuf","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Mazzulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.03.008_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008659","article-title":"Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs","volume":"6","author":"Aflaki","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0010","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.1523\/JNEUROSCI.0636-16.2016","article-title":"A new glucocerebrosidase chaperone reduces alpha-synuclein and glycolipid levels in iPSC-derived dopaminergic neurons from patients with Gaucher disease and parkinsonism","volume":"36","author":"Aflaki","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0020","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.03.008_bb0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0030","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/ncomms5755","article-title":"Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein","volume":"5","author":"Bae","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.03.008_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuint.2015.12.004","article-title":"Advances in GBA-associated Parkinson's disease \u2013 pathology, presentation and therapies","volume":"93","author":"Barkhuizen","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2018.03.008_bb0040","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0003-9861(86)90238-9","article-title":"Comparison of the ability of phospholipids from rat liver lysosomes to reconstitute glucocerebrosidase","volume":"245","author":"Basu","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.nbd.2018.03.008_bb0045","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher disease paradigm: from ERAD to comorbidity","volume":"33","author":"Bendikov-Bar","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2018.03.008_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","article-title":"Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase","volume":"50","author":"Bendikov-Bar","year":"2013","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.nbd.2018.03.008_bb0055","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1060028013500469","article-title":"Gaucher disease and its treatment options","volume":"47","author":"Bennett","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.nbd.2018.03.008_bb0060","doi-asserted-by":"crossref","first-page":"14861","DOI":"10.1016\/S0021-9258(18)82412-7","article-title":"Human acid beta-glucosidase. N-glycosylation site occupancy and the effect of glycosylation on enzymatic activity","volume":"268","author":"Berg-Fussman","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1126\/science.1589760","article-title":"Gaucher disease: new molecular approaches to diagnosis and treatment","volume":"256","author":"Beutler","year":"1992","journal-title":"Science (New York, N.Y.)"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2018.03.008_bb0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jnc.13517","article-title":"Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance","volume":"139","author":"Blanz","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0075","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/tra.12313","article-title":"Mannose 6-phosphate-independent lysosomal sorting of LIMP-2","volume":"16","author":"Blanz","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.nbd.2018.03.008_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002346","article-title":"Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells","volume":"3","author":"Cao","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","article-title":"A53T human -synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration","volume":"35","author":"Chen","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer's disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0100","doi-asserted-by":"crossref","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T \u03b1-synuclein induces neuronal death by increasing mitochondrial autophagy","volume":"286","author":"Choubey","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0105","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.stemcr.2016.08.012","article-title":"Parkin and PINK1 patient iPSC-derived midbrain dopamine neurons exhibit mitochondrial dysfunction and \u03b1-Synuclein accumulation","volume":"7","author":"Chung","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2018.03.008_bb0110","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.wnl.0000276989.17578.02","article-title":"Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease","volume":"69","author":"Clark","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.03.008_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2018.03.008_bb0120","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nbd.2018.03.008_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003985","article-title":"Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease","volume":"4","author":"Cooper","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0130","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant -synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.03.008_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000440865","article-title":"Gaucher disease: clinical, biological and therapeutic aspects","volume":"83","author":"Dandana","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.nbd.2018.03.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005944","article-title":"Glucocerebrosidase deficiency in drosophila results in \u03b1-synuclein-independent protein aggregation and neurodegeneration","volume":"12","author":"Davis","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/hmg\/ddt468","article-title":"Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration","volume":"23","author":"Farfel-Becker","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0150","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","article-title":"ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons","volume":"6","author":"Fernandes","year":"2016","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.nbd.2018.03.008_bb0155","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.15252\/emmm.201505439","article-title":"Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients","volume":"7","author":"Fern\u00e1ndez-Santiago","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb9005","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.03.008_bb0160","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0165","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1523\/JNEUROSCI.5809-11.2012","article-title":"Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of -synuclein and LRRK2 in the brain","volume":"32","author":"Friedman","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0175","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0180","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.03.008_bb0185","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029861","article-title":"High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase","volume":"7","author":"Goldin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.03.008_bb0195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2018.03.008_bb0200","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0006-291X(90)92388-G","article-title":"Human acid beta-glucosidase: glycosylation is required for catalytic activity","volume":"168","author":"Grace","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2018.03.008_bb0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bcmd.2006.02.004","article-title":"Increased incidence of Parkinson disease among relatives of patients with Gaucher disease","volume":"36","author":"Halperin","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2018.03.008_bb0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jnc.13593","article-title":"Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance","volume":"139","author":"Hernandez","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between Progranulin and Gaucher disease","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.nbd.2018.03.008_bb0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","article-title":"Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and Neuromelanin-producing neurons","volume":"19","author":"Jo","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0225","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nn.2243","article-title":"Wnt antagonism of Shh facilitates midbrain floor plate neurogenesis","volume":"12","author":"Joksimovic","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0230","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1091\/mbc.e11-06-0553","article-title":"Two phosphatidylinositol 4-kinases control lysosomal delivery of the Gaucher disease enzyme, beta-glucocerebrosidase","volume":"23","author":"Jovic","year":"2012","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0235","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/14789450.2016.1174583","article-title":"Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its potential implications for Parkinson disease","volume":"13","author":"Jung","year":"2016","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.nbd.2018.03.008_bb0240","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases activity of the Gaucher disease L444P mutant form of \u03b2-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.nbd.2018.03.008_bb0245","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1073\/pnas.1700465115","article-title":"GBA1 deficiency negatively affects physiological alpha-synuclein tetramers and related multimers","volume":"115","author":"Kim","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0250","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1523\/JNEUROSCI.4527-15.2016","article-title":"A drosophila model of neuronopathic Gaucher disease demonstrates lysosomal-autophagic defects and altered mTOR signalling and is functionally rescued by rapamycin","volume":"36","author":"Kinghorn","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0255","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0260","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0265","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0270","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","article-title":"Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation","volume":"24","author":"Li","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0275","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10571-015-0176-8","article-title":"Gaucher-associated parkinsonism","volume":"35","author":"Li","year":"2015","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0280","first-page":"5126","article-title":"Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice","volume":"25","author":"Liou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0285","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature09798","article-title":"Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells","volume":"471","author":"Lister","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0290","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/hmg\/ddw185","article-title":"Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson disease","volume":"25","author":"Magalhaes","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0295","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bo\u011f","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2018.03.008_bb0300","first-page":"777","article-title":"Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy","volume":"118","author":"Martinez-Vicente","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2018.03.008_bb0305","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0310","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"Alpha-synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0315","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","article-title":"Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in Parkinson's patient midbrain neurons","volume":"36","author":"Mazzulli","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0320","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/brain\/awu020","article-title":"Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells","volume":"137","author":"McNeill","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.03.008_bb0325","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.stem.2012.02.014","article-title":"Erosion of dosage compensation impacts human iPSC disease modeling","volume":"10","author":"Mekhoubad","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0330","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuron.2017.01.022","article-title":"Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities","volume":"93","author":"Menzies","year":"2017","journal-title":"Neuron"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2018.03.008_bb0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/jnc.13385","article-title":"The relationship between glucocerebrosidase mutations and Parkinson disease","volume":"139","author":"Migdalska-Richards","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0340","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0345","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0350","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4161\/auto.29074","article-title":"Glucocerebrosidase deficits in sporadic Parkinson disease","volume":"10","author":"Murphy","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2018.03.008_bb0355","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased \u03b1-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.03.008_bb0360","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/43.2.7822772","article-title":"Immunoelectron microscopic localization of mannose-terminal glucocerebrosidase in lysosomes of rat liver Kupffer cells","volume":"43","author":"Murray","year":"1995","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0365","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0370","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type 1 Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.nbd.2018.03.008_bb0375","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nn.3350","article-title":"Interplay of LRRK2 with chaperone-mediated autophagy","volume":"16","author":"Orenstein","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0380","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of Gaucher disease\u2014links to Parkinson's disease","volume":"17","author":"Osellame","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2018.03.008_bb0385","series-title":"Genetic Causes of Parkinson's Disease and their Links to Autophagy Regulation","author":"Pan","year":"2014"},{"key":"10.1016\/j.nbd.2018.03.008_bb0390","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0395","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.nbd.2018.03.008_bb0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.seminhematol.2004.07.009","article-title":"Therapeutic goals in the treatment of Gaucher disease","volume":"41","author":"Pastores","year":"2004","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0405","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/jm300063b","article-title":"Discovery, SAR, and biological evaluation of non-inhibitory small molecule chaperones of glucocerebrosidase","volume":"55","author":"Patnaik","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0410","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.03.008_bb0415","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","article-title":"Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells","volume":"105","author":"Plowey","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.03.008_bb0420","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1021\/bi980785+","article-title":"Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C","volume":"37","author":"Qi","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2018.03.008_bb0425","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0430","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0435","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s13311-014-0294-x","article-title":"A GCase chaperone improves motor function in a mouse model of synucleinopathy","volume":"11","author":"Richter","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2018.03.008_bb0440","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2018.03.008_bb0445","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2015.6307","article-title":"Sustained systemic glucocerebrosidase inhibition induces brain \u03b1-synuclein aggregation, microglia and complement C1q activation in mice","volume":"23","author":"Rocha","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.nbd.2018.03.008_bb0450","series-title":"ER Retention and Degradation as the Molecular Basis Underlying Gaucher Disease Heterogeneity","author":"Ron","year":"2005"},{"key":"10.1016\/j.nbd.2018.03.008_bb0455","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13024-016-0140-1","article-title":"LRRK2 at the interface of autophagosomes, endosomes and lysosomes","volume":"11","author":"Roosen","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.03.008_bb0460","doi-asserted-by":"crossref","first-page":"15573","DOI":"10.1073\/pnas.1405700111","article-title":"LIMP-2 expression is critical for beta-glucocerebrosidase activity and alpha-synuclein clearance","volume":"111","author":"Rothaug","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0465","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","article-title":"Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription","volume":"155","author":"Ryan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.03.008_bb0470","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease","volume":"4","author":"Sanchez-Danes","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb9000","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0475","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0480","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0485","series-title":"Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy","author":"Savitt","year":"2012"},{"key":"10.1016\/j.nbd.2018.03.008_bb0490","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1021\/cb600187q","article-title":"Chemical chaperones and permissive temperatures alter the cellular localization of Gaucher disease associated glucocerebrosidase variants","volume":"1","author":"Sawkar","year":"2006","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Sch\u00f6ndorf","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.03.008_bb0505","first-page":"CD010324","article-title":"Enzyme replacement and substrate reduction therapy for Gaucher disease","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.nbd.2018.03.008_bb0510","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2018.03.008_bb0515","first-page":"273","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"14","author":"Sidransky","year":"2012","journal-title":"Discov. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0520","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of Glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0525","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nature17939","article-title":"Parkinson-associated risk variant in distal enhancer of alpha-synuclein modulates target gene expression","volume":"533","author":"Soldner","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0530","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.03.008_bb0535","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1073\/pnas.0605928103","article-title":"The iminosugar isofagomine increases the activity of N370S mutant acid \u03b2-glucosidase in Gaucher fibroblasts by several mechanisms","volume":"103","author":"Steet","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0540","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"elife"},{"key":"10.1016\/j.nbd.2018.03.008_bb0545","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1093\/hmg\/ddt301","article-title":"Inhibition of excessive mitochondrial fission reduced aberrant autophagy and neuronal damage caused by LRRK2 G2019S mutation","volume":"22","author":"Su","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0550","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0555","article-title":"Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.03.008_bb0560","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1194\/jlr.R047381","article-title":"Development of targeted therapies for Parkinson's disease and related synucleinopathies","volume":"55","author":"Sybertz","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2018.03.008_bb0565","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2018.03.008_bb0570","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.chembiol.2014.06.008","article-title":"ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease","volume":"21","author":"Tan","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0575","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.celrep.2015.08.001","article-title":"VPS35 deficiency or mutation causes dopaminergic neuronal loss by impairing mitochondrial fusion and function","volume":"12","author":"Tang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2018.03.008_bb0580","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","article-title":"VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for -Synuclein degradation and prevention of pathogenesis of Parkinson's disease","volume":"35","author":"Tang","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0585","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2018.03.008_bb0590","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","article-title":"Deficiency of ATP13A2 leads to lysosomal dysfunction, \u03b1-synuclein accumulation and neurotoxicity","volume":"32","author":"Usenovic","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0595","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3983","article-title":"Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0600","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2018.03.008_bb0605","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/01913128809032232","article-title":"An immunoelectron microscopic study of glucocerebrosidase in type 1 Gaucher's disease spleen","volume":"12","author":"Willemsen","year":"1988","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0610","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"\u03b1-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0615","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2018.03.008_bb0620","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.celrep.2014.10.023","article-title":"iPS cell-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease","volume":"9","author":"Woodard","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2018.03.008_bb0625","doi-asserted-by":"crossref","first-page":"13821","DOI":"10.1073\/pnas.0706199104","article-title":"Integrative genomic and functional analyses reveal neuronal subtype differentiation bias in human embryonic stem cell lines","volume":"104","author":"Wu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005515","article-title":"Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy","volume":"4","author":"Xilouri","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.03.008_bb0635","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.26477","article-title":"Autophagy and alpha-synuclein: relevance to Parkinson's disease and related synucleopathies","volume":"31","author":"Xilouri","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2018.03.008_bb0640","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1093\/hmg\/ddu105","article-title":"Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice","volume":"23","author":"Xu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.03.008_bb0645","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev-neuro-071013-014149","article-title":"Autophagy and its normal and pathogenic states in the brain","volume":"37","author":"Yamamoto","year":"2014","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.03.008_bb0650","series-title":"Histone Deacetylase Inhibitors Increase Glucocerebrosidase Activity in Gaucher Disease by Modulation of Molecular Chaperones","author":"Yang","year":"2013"},{"key":"10.1016\/j.nbd.2018.03.008_bb0655","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1073\/pnas.1321341111","article-title":"Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones","volume":"111","author":"Yang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.03.008_bb0660","series-title":"Mutant Glucocerebrosidase in Gaucher Disease Recruits Hsp27 to the Hsp90 Chaperone Complex for Proteasomal Degradation","author":"Yang","year":"2015"},{"key":"10.1016\/j.nbd.2018.03.008_bb0665","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12035-014-8787-5","article-title":"Defective autophagy in Parkinson's disease: lessons from genetics","volume":"51","author":"Zhang","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2018.03.008_bb0670","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.nbd.2018.03.008_bb0675","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1073\/pnas.1514005113","article-title":"Characterization of the complex formed by beta-glucocerebrosidase and the lysosomal integral membrane protein type-2","volume":"113","author":"Zunke","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2018.03.008_bb0680","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","article-title":"Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide","volume":"97","author":"Zunke","year":"2017","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T10:03:03Z","timestamp":1660644183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118300743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":138,"alternative-id":["S0969996118300743"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.03.008","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}